Inventor

WITZTUM JOSEPH L

US26 patents

⚠️ This page may combine multiple inventors who share the name “WITZTUM JOSEPH L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

WITZTUM JOSEPH L

UNIV CALIFORNIA

Reagents and methods for diagnosing, imaging and treating atherosclerotic disease

Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma

Methods and reagents for non-invasive imaging of atherosclerotic plaque

Antibodies to oxidized phospholipids

Antibodies to oxidized phospholipids

Antibodies to oxidized phospholipids

Method of treating rheumatoid arthritis using antibodies to oxidized phospholipids

Therapies and methods to treat TLR2-mediated diseases and disorders

Methods for diagnosing, imaging and treating atherosclerotic disease

Inhibition of oxidation-specific epitopes to treat ischemic reperfusion injury

Reagents for diagnosing, imaging and treating atherosclerotic disease

Isoform-independent antibodies to lipoprotein(a)

Compositions and methods for diagnosis of cardiovascular disease

Oxidative biomarkers in predicting risk of stroke, transient ischemic attack (TIA) and peripheral arterial disease (PAD)

Methods for assessing atherogenesis by determining oxidized phospholipid to apolipoprotein B ratios

Methods and compositions for determining OxPL-associated diseases and disorders

SCRIPPS RESEARCH INST

Nonnatural apolipoprotein B-100 peptides and apolipoprotein B-100-apolipoprotein A-I fusion peptides

DNA encoding recombinant lipoprotein antigens

Apolipoprotein B-specific monoclonal antibodies produced by two novel hybridomas

Apolipoprotein B-specific monoclonal antibodies produced by two novel hybridomas

SCRIPPS CLINIC RES

Assay method and diagnostic system for determining the ratio of APO B-100 to APO A-I in a blood sample

Receptors specific for hapten-modified self proteins

IONIS PHARMACEUTICALS INC

Modulation of apolipoprotein C-III (ApoCIII) expression in lipoprotein lipase deficient (LPLD) populations

TSIMIKAS SOTIRIOS

Methods for assessing atherogenesis by determining oxidized phospholipid to apolipoprotein B ratios

WITZTUM JOSEPH L

Methods to determine atherosclerosis regression, plaque stabilization and cardiovascular risk

VAN NIEUWENHZE MICHAEL S

Peptide-phospholipid conjugates